|
RNF111 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.655400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.603640E-01 |
| Normal-vs-Stage2 |
2.400200E-01 |
| Normal-vs-Stage3 |
1.386770E-04 |
| Normal-vs-Stage4 |
2.34249999999658E-05 |
| Stage1-vs-Stage2 |
7.693800E-01 |
| Stage1-vs-Stage3 |
5.424800E-04 |
| Stage1-vs-Stage4 |
2.447900E-04 |
| Stage2-vs-Stage3 |
9.092500E-02 |
| Stage2-vs-Stage4 |
4.386200E-02 |
| Stage3-vs-Stage4 |
5.958800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.455400E-03 |
| Normal-vs-AfricanAmerican |
7.410200E-04 |
| Normal-vs-Asian |
1.125410E-01 |
| Caucasian-vs-AfricanAmerican |
1.546980E-01 |
| Caucasian-vs-Asian |
1.575770E-02 |
| AfricanAmerican-vs-Asian |
1.700580E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.401400E-03 |
| Normal-vs-Female |
1.024390E-02 |
| Male-vs-Female |
8.865800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.454160E-02 |
| Normal-vs-Age(41-60Yrs) |
8.936000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.380460E-03 |
| Normal-vs-Age(81-100Yrs) |
1.252380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.095800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.449400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.176000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.991600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.906440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.762600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.021800E-01 |
| Normal-vs-Grade 2 |
1.740770E-01 |
| Normal-vs-Grade 3 |
8.359400E-04 |
| Normal-vs-Grade 4 |
3.67499999986975E-07 |
| Grade 1-vs-Grade 2 |
3.622000E-01 |
| Grade 1-vs-Grade 3 |
3.818400E-02 |
| Grade 1-vs-Grade 4 |
9.157800E-04 |
| Grade 2-vs-Grade 3 |
1.184380E-02 |
| Grade 2-vs-Grade 4 |
3.17490000001364E-06 |
| Grade 3-vs-Grade 4 |
6.780700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.569200E-01 |
| Normal-vs-ccB subtype |
3.478500E-03 |
| ccA subtype-vs-ccB subtype |
2.424500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.388000E-02 |
| Normal-vs-N1 |
2.543000E-01 |
| N0-vs-N1 |
6.767400E-01 |
|
|
